B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PIM1

MOLECULAR TARGET

Pim-1 proto-oncogene, serine/threonine kinase

UniProt: P11309NCBI Gene: 529213 compounds

PIM1 (Pim-1 proto-oncogene, serine/threonine kinase) is targeted by 13 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PIM1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Quercetin2.087
2ly2940022.087
3Apigenin 5,7,4'-trihydroxy-flavone,1.393
4myricetin-3-O-galactopyranoside [Supplementary Concept]1.393
5kenpaullone1.393
6sp6001251.393
7fisetin1.102
8Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as1.102
9Kaempferols0.691
10Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
11alsterpaullone0.691
12Colchicine0.691
13piceatannol0.691

About PIM1 as a Drug Target

PIM1 (Pim-1 proto-oncogene, serine/threonine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 13 compounds with documented PIM1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PIM1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.